Problem solving in psychopharmacotherapy using pharmacokinetic and pharmacogenetic tests
2009-01-24 - English

Many problems such as non-response, pharmacokinetic interactions with clinical consequences and adverse effects (pharmacovigilance) may be observed in patients submitted to psychopharmacotherapy. These risks are increased in patients belonging to the category of “special...(more)

Problem solving in psychopharmacotherapy using pharmacokinetic and pharmacogenetic tests
2009-01-24 - English

A widely introduced pharmacokinetic test in psychopharmacotherapy is therapeutic drug monitoring (TDM). It is especially recommended in patients who are non-compliant, who poorly tolerate, or who do not respond to a medication. It is also useful in patients belonging to the...(more)

Metabolic risks and outcome in psychosis in Sweden
2009-01-25 - English

DIABETES, DIET AND SMI: HOW CAN WE MAKE A DIFFERENCE?
2009-01-25 - English

Atypical antipsychotics and screening of glucose
2009-01-25 - English

D. Cohen¹, H. Burger², C. Gispen de Wied³, R. Stolk¹, D. Grobbee^4
1Clinical Epidemiology, University of Groningen, ²Interdisciplinary Center for Psychiatric Epidemiology, University...(more)